AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.360
+0.040 (1.72%)
Aug 7, 2026, 4:00 PM EDT - Market closed
AC Immune Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27.76 | 26.8 | 36.28 | 78.49 | 31.59 | 82.22 |
Short-Term Investments | 47.6 | 64.62 | 129.21 | 24.55 | 91 | 116 |
Cash & Short-Term Investments | 75.36 | 91.41 | 165.49 | 103.05 | 122.59 | 198.22 |
Cash Growth | -40.73% | -44.76% | 60.59% | -15.94% | -38.16% | -12.25% |
Accounts Receivable | 9.92 | - | - | 14.8 | - | - |
Other Receivables | 3.72 | 1.34 | 2.2 | 0.87 | 0.8 | 1.4 |
Total Trade Receivables | 13.65 | 1.34 | 2.2 | 15.67 | 0.8 | 1.4 |
Other Current Assets | 4.4 | 3.97 | 4.3 | 6.44 | 4.71 | 3.02 |
Total Current Assets | 93.4 | 96.72 | 171.99 | 125.15 | 128.09 | 202.63 |
Net Property, Plant & Equipment | 6 | 6.53 | 8.09 | 6.88 | 7.07 | 8.03 |
Other Intangible Assets | 50.42 | 50.42 | 50.42 | 50.42 | 50.42 | 50.42 |
Long-Term Investments | 0.59 | 0.58 | 0.42 | 0.36 | 0.36 | 0.36 |
Total Assets | 150.4 | 154.25 | 230.91 | 182.81 | 185.94 | 261.44 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.51 | 2.07 | 2.66 | 1.68 | 0.93 | 2 |
Accrued Expenses | 7.12 | 8.07 | 12.1 | 11.09 | 9.42 | 16.74 |
Current Portion of Leases | 0.84 | 0.85 | 1.03 | 0.67 | 0.55 | 0.57 |
Unearned Revenue | 90.77 | 83.71 | 85.06 | 0.14 | 0.59 | 0.72 |
Total Current Liabilities | 100.24 | 94.69 | 100.84 | 13.58 | 11.48 | 20.03 |
Long-Term Leases | 3.27 | 3.69 | 4.4 | 2.83 | 2.25 | 2.34 |
Other Long-Term Liabilities | 11.73 | 10.99 | 13.4 | 5.77 | 3.21 | 7.1 |
Total Long-Term Liabilities | 14.99 | 14.67 | 17.81 | 8.6 | 5.47 | 9.44 |
Total Liabilities | 115.23 | 109.37 | 118.64 | 22.17 | 16.95 | 29.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.26 | 2.25 | 2.23 | 2.09 | 1.8 | 1.79 |
Treasury Stock | -0.21 | -0.22 | -0.22 | -0.11 | -0.12 | -0.12 |
Additional Paid-in Capital | 483.55 | 481.86 | 478.51 | 474.91 | 431.32 | 431.25 |
Accumulated Other Comprehensive Income | 0.01 | 0.01 | -0.01 | -0.05 | 0.01 | - |
Retained Earnings | -450.44 | -439.02 | -368.24 | -316.2 | -264.02 | -200.94 |
Shareholders' Equity | 35.17 | 44.88 | 112.27 | 160.64 | 168.99 | 231.98 |
Total Liabilities & Equity | 150.4 | 154.25 | 230.91 | 182.81 | 185.94 | 261.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.1 | 4.54 | 5.43 | 3.5 | 2.8 | 2.91 |
Net Cash (Debt) | 71.26 | 86.87 | 160.06 | 99.55 | 119.79 | 195.31 |
Net Cash Growth | -41.70% | -45.73% | 60.78% | -16.89% | -38.67% | -12.68% |
Net Cash Per Share | 0.70 | 0.86 | 1.61 | 1.18 | 1.43 | 2.61 |
Book Value | 35.17 | 44.88 | 112.27 | 160.64 | 168.99 | 231.98 |
Book Value Per Share | 0.35 | 0.45 | 1.13 | 1.90 | 2.02 | 3.10 |
Tangible Book Value | -15.25 | -5.53 | 61.85 | 110.23 | 118.58 | 181.56 |
Tangible Book Value Per Share | -0.15 | -0.05 | 0.62 | 1.30 | 1.42 | 2.42 |